Search

for
Search:

GlossaryClofazimine

antibiotic used to treat leprosy by inhibiting bacterial growth

Clofazimine is an antibiotic primarily used to treat leprosy, a chronic infectious disease caused by Mycobacterium leprae. It works by binding to the DNA of the bacteria, inhibiting their growth and reducing inflammation. While it is effective in managing leprosy, it can cause side effects such as skin discoloration and gastrointestinal issues.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 84 results

research Ashy Dermatosis: Treatment with Clofazimine

April 2012 in “Journal of the American Academy of Dermatology”

Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.

research Delusions of Parasitosis: World Perspective on the Choice of Psychopharmacotherapy

1 citations, April 2012 in “Journal of the American Academy of Dermatology”

Clofazimine effectively treated a rare skin condition with ash-gray patches.

research Cortexolone 17a-Propionate: Preclinical Profile of a New Topical, Skin Selective, Steroidal Antiandrogen

April 2012 in “Journal of the American Academy of Dermatology”

Clofazimine may be effective for treating ashy dermatosis.

Baseline Methotrexate Does Not Impact the Incidence of Infliximab Infusion Reactions: Results from a Canadian Real-World Treatment Registry

research Baseline Methotrexate Does Not Impact the Incidence of Infliximab Infusion Reactions: Results from a Canadian Real-World Treatment Registry

April 2012 in “Journal of the American Academy of Dermatology”

Clofazimine effectively treated ashy dermatosis in a patient.

research Cutaneous Lupus Erythematosus: A Comprehensive Review

74 citations, March 2001 in “Seminars in Cutaneous Medicine and Surgery”

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

View more "clofazimine" in research →

Community Join

0 / 0 results

— no results